Global Sinus Dilation Devices Market - 2022-2029

Market Overview

The global sinus dilation devices market was valued at US$ 3,516.43 million in 2021 and is estimated to reach US$ 4,983.72 million by 2029, growing at a CAGR of 5.07% during the forecast period (2022-2029).

Sinus infection involves swelling of nasal passages or sinuses, also known as sinusitis. Sinus dilation devices are used in the surgical treatment of sinus disease. The satisfactory results of these devices in patients with chronic sinusitis have increased their adoption in recent years. Chronic sinusitis and related conditions are a dominant medical problem worldwide.

Market Dynamics

Increased prevalence of chronic sinusitis, increased regulatory approval of medical dilation devices, adoption of minimally invasive surgery, and ongoing research and development activities are driving the global sinus dilation devices market during the forecast period.

The increasing number of novel product launches and the rising research and development will drive market growth.

The global market for sinus dilation devices is primarily driven by the high prevalence of chronic sinusitis and a growing preference for minimally invasive surgeries. Other factors aiding the market growth are favorable reimbursement scenarios growing the healthcare market in emerging economies.

Technological advancements in sinusitis treatments and the benefits of balloon sinus dilation over conventional operations contribute to the global sinus dilation devices market. For instance, in Feb 2022, Medtronic Plc, a healthcare technology company, launched its novel Eustachian tube dilation balloon named NuVent, approved by the U.S. FDA. NuVent helps surgeons deliver appropriate office or outpatient setting treatment. The flexible balloon section can be customized for placement based on a patient's anatomy.

Various funding, novel technological advancements, and the number of the latest, innovative product launches are increasing, leading to the high demand for sinus dilation devices. For instance, in Sep 2021, Acclarent Inc, Johnson & Johnson Medical Device Subsidiary, which designs minimally invasive ENT technologies, launched its AI-powered ENT technology that will simplify surgical planning and, during ENT navigation procedures, will give feedback. This software will use TruPath and TruSeg with the TruDi navigation system and provide efficient image-guided navigation and planning for ENT surgeries such as endoscopic sinus surgery.

The presence of alternatives and high costs associated with sinus dilation devices will hamper the market's growth.

However, high costs associated with sinus dilation device equipment and the low preference for sinus surgical procedures due to sinusitis drugs may hinder market progress. Over-the-counter drugs account for much of the expense yet provide minimal benefit in most patients with chronic sinusitis.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The sinus dilation devices market has experienced huge losses due to COVID, as all the research and clinical trials got affected due to the diversion of attention toward COVID. But now, the market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Various initiatives, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jul 2020, Optim LLC, a proprietary endoscopes manufacturer, announced its partnership with MedShare for donating its ENTity Nasopharyngoscopes to under-served communities globally.

Segment Analysis

The balloon sinus dilation devices are expected to grow at the fastest CAGR during the forecast period (2022-2029)

Balloon sinus dilation devices are the highest market holder in the global sinus dilation devices market. Balloon sinus dilation is a procedure in which, under endoscopic visualization, a flexible balloon catheter is inserted into the sinus passages blocked by an ENT surgeon. After the balloon placement, it is inflated to open the sinus cavity. To flush out pus or mucus, they inject a saline solution. This reduces the trauma caused to delicate tissues in the passage. After the drainage of fluid, the patient feels relieved.

The balloon sinus dilation device segment dominates the market due to the demand for these devices and rising global sinusitis infection cases. The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in May 2022, Dalent Medical, a medical technology company that designs innovative devices for sinus treatment, acquired a new patent in its intellectual property portfolio. This patent protects the Sinusleeve balloon, Dalen's proprietary balloon sinus dilation device for chronic sinusitis treatment.

Geographical Analysis

North America holds the largest market share of the global sinus dilation devices market.

North America dominates the global sinus dilation devices market, primarily attributed to the increase in the prevalence of chronic sinusitis, increase in pharmaceutical establishment across the region and government approvals, increase in adoption of minimally invasive surgical procedures in recent years, and presence of key players in the region are contributing to the growth of sinus dilation devices market. According to the Sinus and Allergy Wellness Centre report 2021, Sinusitis affects approximately 30 million adults, about 11.6% of the adult population in the United States.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations and agreements are taking place in this region. For instance, in Aug 2022, Acclarent Inc, Johnson & Johnson Medical Device Subsidiary, which designs minimally invasive ENT technologies, announced that its TruDi shaver blade, a single-use electromagnetically navigated blade, got clearance from U.S. Food and Drug Administration. TruDi can be used for the removal or incision of tissues or bones in ENT.

Competitive Landscape

The sinus dilation devices market is moderately competitive with local and global companies' presence. Medtronic Plc, Smith and Nephew Plc, Acclarent, Inc., Stryker, Olympus Corporation, Optim LLC, Cook Medical, Summit Health Medical, Dalent Medical, Meril Life Sciences and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Feb 2022, Olympus, an innovative solution developer for surgical and medical procedures, announced that its single-use sinus debrider system CELERIS received clearance from the U.S. Food and Drug Administration.

Medtronic Inc.:

Overview:

Medtronic plc is a healthcare technology company that develops, manufactures and markets medical devices. It was established in 1949 and is headquartered in Dublin, Ireland. It is operational in around 140 countries, and 90,000 people are employed there.

Product Portfolio:

NuVent EM Sinus Dilation System: NuVent balloon dilation is a targeted system used for balloon sinus surgery with a built-in electromagnetic surgical navigation technology. It provides a different and unique addition to sinus surgery treatment.

Key Development: In May 2022, Medtronic Plc, a healthcare technology company, announced the completion of the acquisition of Intersect ENT. This acquisition will help Medtronic expand its ENT portfolio in sinus procedures for nasal polyps treatment.

The global sinus dilation devices market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.